FOXP3 and neoplasm: The tumor tissue-infiltrated CD4+ FOXP3+ Treg were also increased after CAF depletion, which reduced tumor response to gemcitabine treatment via cytotoxic T-lymphocyte-associated protein (CTLA)-4-induced immunosuppression (14).